Celldex Therapeutics buy TD Cowen
Start price
20.12.23
/
50%
€35.40
Target price
20.12.24
-
Performance (%)
-11.86%
Price
08:00
€31.20
Summary
This prediction is currently active. The price of Celldex Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.86%. This prediction currently runs until 20.12.24. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -22.330% | -22.330% |
| iShares Core DAX® | -3.935% | -3.998% |
| iShares Nasdaq 100 | -3.608% | -9.386% |
| iShares Nikkei 225® | -4.513% | -8.017% |
| iShares S&P 500 | -2.607% | -4.265% |
Comments by TD_Cowen for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.
Ratings data for CLDX provided by MarketBeat